This trial is testing whether the PRISM intervention can help adolescents and young adults with advanced cancer manage stress.
1 Primary · 8 Secondary · Reporting Duration: 3-months
Active Control
Experimental Treatment
195 Total Participants · 2 Treatment Groups
Primary Treatment: Promoting Resilience in Stress Management (PRISM) · No Placebo Group · Phase 3
Age 12 - 24 · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Texas | 66.7% |
California | 33.3% |
18 - 65 | 100.0% |
Children's Hospital Los Angeles | 50.0% |
Texas Children's Hospital | 50.0% |
Met criteria | 66.7% |
Did not meet criteria | 33.3% |